XML 100 R13.htm IDEA: XBRL DOCUMENT
v3.26.1

Investment in receivables, net | 3 Months Ended
--- | ---
Mar. 31, 2026
Investment in receivables, net |
Investment in receivables, net | 5.Investment in receivables, net The following table presents the roll forward of the balance of the investment in receivables, net for the following periods (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the Three Months Ended
​ | ​ | March 31,
​ | ​ ​ ​ | 2026 | ​ ​ ​ | 2025
Balance, beginning of year | ​ | $ | 1,928,742 | ​ | $ | 1,497,748
Purchases | ​ | ​ | 149,705 | ​ | ​ | 175,222
Cash collections | ​ | ​ | (309,898) | ​ | ​ | (260,891)
Total portfolio income | ​ | ​ | 157,606 | ​ | ​ | 138,693
Changes in expected current period recoveries | ​ | ​ | 10,731 | ​ | ​ | 6,398
Changes in expected future period recoveries | ​ | ​ | (3,674) | ​ | ​ | (2,777)
Foreign currency adjustments | ​ | ​ | (4,143) | ​ | ​ | 7,202
Balance, end of period | ​ | $ | 1,929,069 | ​ | $ | 1,561,595
​ The table below provides the detail on the establishment of negative allowance for expected recoveries of portfolios purchased during the periods presented (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the Three Months Ended | ​
​ | ​ | March 31, | ​
​ | ​ ​ ​ | 2026 | ​ ​ ​ | 2025 | ​ ​ ​
Purchase price | ​ | $ | 149,705 | ​ | $ | 175,222 | ​
Allowance for credit losses | ​ | ​ | 2,417,429 | ​ | ​ | 2,434,302 | ​
Amortized cost | ​ | ​ | 2,567,134 | ​ | ​ | 2,609,524 | ​
Noncredit discount | ​ | ​ | 141,038 | ​ | ​ | 147,851 | ​
Face value | ​ | ​ | 2,708,172 | ​ | ​ | 2,757,375 | ​
Write-off of amortized cost | ​ | ​ | (2,567,134) | ​ | ​ | (2,609,524) | ​
Write-off of noncredit discount | ​ | ​ | (141,038) | ​ | ​ | (147,851) | ​
Negative allowance | ​ | ​ | 149,705 | ​ | ​ | 175,222 | ​
Negative allowance for expected recoveries | ​ | $ | 149,705 | ​ | $ | 175,222 | ​
​ For the three months ended March 31, 2026, the Company purchased receivable portfolios with face values of $2,708.2 million for a purchase price of $149.7 million or 5.5% of face value. For the three months ended March 31, 2025, the Company purchased receivable portfolios with face values of $2,757.4 million for a purchase price of $175.2 million or 6.4% of face value. The price paid relative to the face amount of receivables will vary based upon the type of debt purchased, the age of the debt at the time of acquisition and the overall debt acquisition market. The percentage reported represents the weighted average of activity for the period and is a function of the mix of assets acquired in any period. For the receivables purchased in the three months ended March 31, 2026 and 2025, the estimated amount of cash flows to be collected were $290.7 million and $323.1 million (as of purchase), respectively. Recoveries above or below forecast represent over and under-performance in the reporting period, respectively. Actual collections during the three months ended March 31, 2026, and 2025, overperformed the projected collections by approximately $10.7 million and $6.4 million, respectively, primarily driven by continued strong collection performance. When reassessing the forecasts of expected lifetime recoveries during the three months ended March 31, 2026, management considered historical and current collection performance and believes that for certain static pools sustained collections overperformance resulted in decreased total future expected recoveries. As a result, the Company has updated its forecast, resulting in a net decrease of total estimated remaining collections, which in turn, when discounted to present value, resulted in a change in expected future period recoveries of approximately $3.7 million and $2.8 million during the three months ended March 31, 2026, and 2025, respectively. At the time of the Bluestem portfolio purchase, which consisted primarily of performing receivables, the Company established an allowance for credit losses of $304.8 million. Additionally, the Company also established a non-credit premium of $93.4 million at the time of purchase. The Company places performing receivables on nonaccrual status when the receivables are greater than 90 days. To facilitate the monitoring of credit quality for performing receivables, and for the purpose of determining an appropriate allowance for losses for these receivables, the Company utilizes payment history and current payment status. The table below presents the information on the past due and non-accrual buckets for the assets acquired in the Conn’s and Bluestem portfolio purchases, and does not include all other purchased loans as they were charged-off at the time of purchase (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​
​ | ​ | As of March 31, | ​ | As of December 31,
Delinquency vintage | ​ ​ ​ | 2026 | ​ ​ ​ | 2025
United States | ​ | ​ | ​ | ​ | ​ | ​
Current | ​ | $ | 217,681 | ​ | $ | 326,381
30-59 | ​ | ​ | 26,602 | ​ | ​ | 49,467
60-89 | ​ | ​ | 19,470 | ​ | ​ | 39,402
>90 | ​ | ​ | 145,137 | ​ | ​ | 109,562
Total | ​ | $ | 408,890 | ​ | $ | 524,812
​ The following table presents non-accrual performing loans by segment (in thousands).
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | As of March 31, | ​ | As of December 31,
​ | ​ | 2026 | ​ | 2025
​ | ​ | ​ | ​ | ​ | Nonaccrual | ​ | ​ | ​ | ​ | Nonaccrual
​ | ​ | ​ | ​ | ​ | with No | ​ | ​ | ​ | ​ | with No
​ | ​ ​ ​ | Nonaccrual | ​ ​ ​ | Allowance | ​ ​ ​ | Nonaccrual | ​ ​ ​ | Allowance
United States | ​ | ​ | 145,137 | ​ | ​ | — | ​ | ​ | 109,562 | ​ | ​ | —
Total | ​ | $ | 145,137 | ​ | $ | — | ​ | $ | 109,562 | ​ | $ | —
​

X
- Definition The entire disclosure for financing receivable. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 12A -Publisher FASB -URI https://asc.fasb.org/1943274/2147481933/310-10-55-12A Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481962/310-10-50-42 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 44 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481962/310-10-50-44 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/310-10/tableOfContent Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 310 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/310-20/tableOfContent + Details
Name: | us-gaap_FinancingReceivablesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ReceivablesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration